Structure-Based Design of an in Vivo Active Selective BRD9 InhibitorLaetitia J. Martin, Darryl B. McConnell, Herbert Nar et al.|Journal of Medicinal Chemistry|2016Cited by 227
Locking mixed-lineage kinase domain-like protein in its auto-inhibited state prevents necroptosisMartin Rübbelke, Markus Zeeb, Dennis Fiegen et al.|Proceedings of the National Academy of Sciences|2020Cited by 48
A small-molecule inhibitor of lectin-like oxidized LDL receptor-1 acts by stabilizing an inactive receptor tetramer stateGisela Schnapp, Dennis Fiegen, Heike Neubauer et al.|Communications Chemistry|2020Cited by 22
Hybrid Screening Approach for Very Small Fragments: X-ray and Computational Screening on FKBP51Sebastian W. Draxler, Dennis Fiegen, Margit Bauer et al.|Journal of Medicinal Chemistry|2020Cited by 18
CRYSTAL STRUCTURE OF LECTIN-LIKE OX-LDL RECEPTOR 1 IN COMPLEX WITH BI-0115Herbert Nar, Gisela Schnapp, Dennis Fiegen|Unknown|2019Cited by 0